SCHEMBL7388010

SCHEMBL7388010

CC(C)=CCN(c1ccc(C(C)C)cc1)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.54
ALDH1A1 P00352 1/20 0.54
MAPT P10636 1/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
RAB9A P51151 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
CACNA1B Q00975 7/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
GPR119 Q8TDV5 8/20 0.42
NR3C1 P04150 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7393443 0.88 CACNA1B (0.51) NPC1ALDH1A1MAPTMAPK1HTT
SCHEMBL7036969 0.87 MEN1 (0.46) CACNA1BMEN1KMT2AGPR119
SCHEMBL7429335 0.86 CACNA1B (0.52) NPC1ALDH1A1MAPTMAPK1HTT
SCHEMBL7037543 0.84 CACNA1B (0.60) CACNA1BMEN1KMT2AGPR119
SCHEMBL7385841 0.84 CACNA1B (0.51) CACNA1BMEN1KMT2AGPR119
SCHEMBL7424188 0.81 CACNA1B (0.58) CACNA1B
SCHEMBL7383571 0.81 CACNA1B (0.58) CACNA1B
SCHEMBL7040340 0.81 CACNA1B (0.69) CACNA1BMEN1KMT2A
SCHEMBL7421570 0.80 CACNA1B (0.43) ALDH1A1CACNA1B
SCHEMBL10159468 0.79 MEN1 (0.62) ALDH1A1MEN1KMT2AGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251919-B1 ADMINISTERING ANILINE DERIVATIVE FOR THERAPY OF PAIN WARNER-LAMBERT 2001-06-26 US disclosed
WO-1999043658-A1 HETEROCYCLIC SUBSTITUTED ANILINE CALCIUM CHANNEL BLOCKERS WARNER-LAMBERT COMPANY (US) 1999-09-02 WO disclosed